Quick Takeaways
- Jane A. Gross has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $39,000.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jane A. Gross
- Location
- Seattle, WA
- Summary
- The estimated net worth of Jane A. Gross is at least $39,000 dollars as of 02 May 2025. Jane A. Gross is the Director of aTYR PHARMA INC and owns shares of aTYR PHARMA INC (ATYR) stock worth about $39K.
- Signature
- /s/ Nancy E. Denyes, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jane A. Gross and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: aTYR PHARMA INC ($39,000).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jane A. Gross
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | Director | $39,000 | 01 May 2025 | ||
| BCTX, BCTXL | BriaCell Therapeutics Corp. | Director | 01 Aug 2022 |
Insider Transactions Reported by Jane A. Gross:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.